Projekt

The trillions of microbes that inhabit our gut, collectively known as the microbiome, affect many aspects of human health. It is now appreciated that alteration in composition and activity of the microbiome can contribute to diseases that plague modern civilization, such as obesity and diabetes, by inducing metabolic inflammation. Specifically, aberrations in microbiota composition and microbiota-derived metabolites have been linked to educating the immune system and to regulating weight gain and blood sugar levels. The foundation of this collaborative research project is the observation that by controlling a single gene that regulates the immune system, called interferon beta, the scientists can change the microbiome and affect weight gaining and obesity. To this end, they designed a unique international team of scientists that are experts in their respective fields to study this phenomenon and provide novel therapeutic treatments for obesity and diabetes.

• Prof. Dr. Till Strowig

  Helmholtz-Zentrum für
  Infektionsforschung GmbH
  Department of Microbial Immune Regulation
  Braunschweig
  

• Prof. Amiram Ariel, D. Phil

  University of Haifa
  Faculty of Natural Sciences
  Department of Human Biology
  Haifa
  Israel
  

• Dr. Shai Bel

  Bar Ilan University
  Medicine
  Safed
  Israel